lumimeds olympia tirzepatide Special Offer Tirzepatide How to Inject Your Semaglutide/Tirzepatide

As a glucagon-like peptide-1 (GLP-1) receptor agonist, Semaglutide influences appetite and food intake, offering a novel approach to addressing obesity

This section looks at the available safety data, what clinical trials have shown, and what this means for people using the medication

Trial SOUL (McGuire et al., NEJM 2025) Design Phase 3 / event-driven Population Adults with T2D + ASCVD or CKD Key result Oral semaglutide significantly reduced MACE vs placebo in high-CV-risk T2D

So semaglutide is also incretin memetic glucagon-like peptide 1 that helps in insulin secretion and also makes you feel non-hungry and ensures delay of stomach emptying time